Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning-based identification of causative genes in lissencephaly using 3D-MRI volumetric datasets.

Neuroimage. Reports·2026
Same author

Morphological symmetry-aware generalized policy network for deep reinforcement learning.

Frontiers in robotics and AI·2026
Same author

Efficacy of Triclosan-Coated Barbed Sutures for Fascial Closure in Colorectal Surgery.

The Journal of surgical research·2026
Same author

Obstructive rectal cancer incidentally diagnosed after a barium meal study: a case report of sequential endoscopic stenting and elective laparoscopic resection.

International journal of surgery case reports·2026
Same author

Quadruply Bridging Strategy Intensifies Circularly Polarized Luminescence of Azapyrenophanes.

Journal of the American Chemical Society·2026
Same author

Effectiveness of Long-Term Shichimotsukokato Administration on the eGFR Slope in Patients With Chronic Kidney Disease: A Retrospective Single-Arm Study.

Cureus·2026

Related Experiment Video

Updated: Jun 9, 2026

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
08:17

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration

Published on: February 27, 2018

[Dementia and fracture].

Yoshihiro Sato1

  • 1Mitate Hospital.

Clinical Calcium
|September 3, 2010
PubMed
Summary
This summary is machine-generated.

Patients with Alzheimer's disease (AD) have a high risk of hip fractures. Vitamin D and K deficiencies contribute to this risk, but treatments like menatetrenone and sunlight exposure can improve bone health.

More Related Videos

Assessment of Bone Fracture Healing Using Micro-Computed Tomography
12:04

Assessment of Bone Fracture Healing Using Micro-Computed Tomography

Published on: December 9, 2022

Related Experiment Videos

Last Updated: Jun 9, 2026

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration
08:17

A Mouse Model of Orthopedic Surgery to Study Postoperative Cognitive Dysfunction and Tissue Regeneration

Published on: February 27, 2018

Assessment of Bone Fracture Healing Using Micro-Computed Tomography
12:04

Assessment of Bone Fracture Healing Using Micro-Computed Tomography

Published on: December 9, 2022

Area of Science:

  • Gerontology
  • Neurology
  • Orthopedics

Background:

  • Alzheimer's disease (AD) patients experience a high incidence of fractures, especially hip fractures, due to falls and potential osteoporosis.
  • The odds ratio for fracture prevalence in elderly individuals with AD compared to those without is 6.9.
  • Previous research indicated that 25-hydroxyvitamin D deficiency (from sun deprivation) and vitamin K deficiency (from malnutrition) in AD patients reduce bone mineral density and increase hip fracture risk.

Purpose of the Study:

  • To investigate the link between vitamin deficiencies and hip fracture risk in Alzheimer's disease patients.
  • To evaluate the efficacy of treatments for improving bone mineral density and reducing fracture risk in this population.

Main Methods:

  • The study analyzed fracture prevalence and risk factors in elderly patients with Alzheimer's disease.
  • Bone mineral density was assessed in relation to vitamin D and vitamin K levels.
  • The impact of treatments including menatetrenone, risedronate, and regular sunlight exposure was evaluated.

Main Results:

  • Deficiencies in 25-hydroxyvitamin D and vitamin K were found to be associated with reduced bone mineral density and a high risk of hip fracture in AD patients.
  • Treatment with menatetrenone, risedronate, or regular sunlight exposure demonstrated safety and effectiveness.
  • These interventions successfully increased bone mass and reduced the risk of hip fracture in patients with AD.

Conclusions:

  • Vitamin D and K deficiencies are significant contributors to hip fractures in Alzheimer's disease patients.
  • Menatetrenone, risedronate, and regular sunlight exposure are effective strategies for enhancing bone health and mitigating fracture risk in AD.
  • Addressing nutritional and environmental factors is crucial for managing bone health in individuals with Alzheimer's disease.